Company: ZCARW
Filing Date: 2025-05-12
Form Type: S-1/A
Source: 0001213900-25-041769
Chunk: 105

Company: Zoomcar Holdings, Inc.
Filing Date: 2025-05-12
Form: S-1/A
Chunk 105
---
 |            |  13.3 | % |
| Total Use of Proceeds                 |     | $                       | 15,000,000 |     |            | 100.0 | % |     | $                    | 7,500,000 |     |            | 100.0 | % |     | $                    | 3,750,000 |     |            | 100.0 | % |

| (1) | Reflects Placement Agent fees equal to 8% of gross                                
 proceeds and a non-accountable expense allowance equal to 0.5% of gross proceeds. |

A $1.00 increase or decrease in the assumed public offering price of $4.07 per share would increase or decrease the net proceeds from this offering by approximately $3,372,237, assuming that the number of share offered by us, as set forth on the cover page of this prospectus, remains the same and after deducting the estimated Placement Agent fees. The actual allocation of proceeds realized from this offering will depend upon our operating revenue, cash position, our working capital requirements. Therefore, as of the date of this prospectus, we cannot specify with certainty all of the particular uses for the net proceeds to be received upon the completion of this offering. Accordingly, we will have discretion in the application of the net proceeds, and investors will be relying on our judgment regarding the application of the proceeds of this offering. Pending our use of the net proceeds from this offering, we intend to invest the net proceeds in a variety of capital preservation investments, including short-term, investment-grade, interest-bearing instruments and U.S. government securities. 55 CAPITALIZATION The following table sets forth our cash and cash equivalents and consolidated capitalization as of December 31, 2024:

| ● | On an actual basis;                                                                                                                           |
| ● | On a pro forma basis, giving effect to (a) the closing of the                                                                                 
 January/February Offering which was closed on February 4, 2025, for the issuance of an aggregate of (i) 52,490 shares of Common Stock,        
 (ii) Pre-Funded Warrants exercisable for an aggregate of 43,600 shares of Common Stock, at an exercise price of $0.002 per share, (iii)       
 January/February Series A Warrants including Placement Agent Warrants to purchase up to a maximum of 1,651,544 shares of Common Stock,        
 at an exercise price of $6.24 per share